What exactly is Tirzepatide, and why do research programs pick the 60mg tier?
Tirzepatide is a 39-amino-acid dual agonist that activates both the GIP and GLP-1 receptors, and it has been the workhorse of dual-incretin research since it entered pre-clinical literature. The 60mg per vial tier is Prescott’s extended-cohort format — twice the peptide mass of the standard TR30 vial, cutting per-vial reconstitution overhead in half for programmes that run long dose-ranging series, bulk in-vitro incubations, or multi-arm designs that would otherwise chew through several smaller vials per week.
What does this specific lot’s CoA cover?
Each Tirzepatide lot is analysed by reverse-phase HPLC for purity and by mass spectrometry against the theoretical 39-amino-acid backbone mass, with the C20 fatty-acid diacid modification confirmed. Lot-specific certificates of analysis are being catalogued and will be attached to the product page as they clear QC.
How do I reconstitute a 60mg Tirzepatide vial?
- Equilibrate the vial to room temperature and sanitize the stopper with an alcohol swab.
- Draw 1 to 2 mL of bacteriostatic water — because peptide mass is high, expect a slightly more viscous solution than the 30mg tier at the same volume.
- Direct the diluent down the glass wall so the cake wets progressively rather than crashing out.
- Rotate the vial slowly until fully clear; avoid shaking or vortexing.
- Store at 2 to 8 °C after reconstitution and use within 30 days.
Tirzepatide 60mg vs the 30mg TR30 tier
TR30 is the standard research tier — appropriate for typical cohort sizes, protocol-development runs, or programmes that don’t want to hold more mass than needed per vial. TR60 is the extended-cohort choice: the same molecule at double the mass, which means one vial covers what would otherwise take two of the smaller tier. Reconstitution volumes and storage windows are identical.
How does Tirzepatide compare with Retatrutide?
Tirzepatide activates GIP and GLP-1 receptors. Retatrutide (RT10) is a triple agonist that adds a glucagon receptor arm to that same pair. Programmes studying whether the added glucagon input shifts pre-clinical energy-expenditure or glycemic-control readouts typically carry both molecules and treat receptor coverage as an experimental variable.
What ships in the box, and how fast?
- 10 lyophilized Tirzepatide 60mg vials
Orders placed before 14:00 PT ship same business day from Prescott Bio’s British Columbia facility; Canadian delivery is 2 to 4 business days after dispatch.
